BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25738872)

  • 1. RUNX2 and Osteosarcoma.
    Li N; Luo D; Hu X; Luo W; Lei G; Wang Q; Zhu T; Gu J; Lu Y; Zheng Q
    Anticancer Agents Med Chem; 2015; 15(7):881-7. PubMed ID: 25738872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines.
    Lucero CM; Vega OA; Osorio MM; Tapia JC; Antonelli M; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Physiol; 2013 Apr; 228(4):714-23. PubMed ID: 22949168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
    Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
    Villanueva F; Araya H; Briceño P; Varela N; Stevenson A; Jerez S; Tempio F; Chnaiderman J; Perez C; Villarroel M; Concha E; Khani F; Thaler R; Salazar-Onfray F; Stein GS; van Wijnen AJ; Galindo M
    J Cell Physiol; 2019 Aug; 234(8):13659-13679. PubMed ID: 30637720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX2 expression in developing human bones and various bone tumors.
    Sugawara M; Kato N; Tsuchiya T; Motoyama T
    Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
    Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
    J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.
    Yang J; Zhao L; Tian W; Liao Z; Zheng H; Wang G; Chen K
    BMC Med Genomics; 2013 Dec; 6():56. PubMed ID: 24330824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.
    van der Deen M; Akech J; Lapointe D; Gupta S; Young DW; Montecino MA; Galindo M; Lian JB; Stein JL; Stein GS; van Wijnen AJ
    J Biol Chem; 2012 Feb; 287(7):4503-17. PubMed ID: 22158627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.
    Kurek KC; Del Mare S; Salah Z; Abdeen S; Sadiq H; Lee SH; Gaudio E; Zanesi N; Jones KB; DeYoung B; Amir G; Gebhardt M; Warman M; Stein GS; Stein JL; Lian JB; Aqeilan RI
    Cancer Res; 2010 Jul; 70(13):5577-86. PubMed ID: 20530675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.
    San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M
    J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
    Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
    J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research findings working with the p53 and Rb1 targeted osteosarcoma mouse model.
    Lu Y; Gitelis S; Lei G; Ding M; Maki C; Mira RR; Zheng Q
    Am J Cancer Res; 2014; 4(3):234-44. PubMed ID: 24959378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis.
    Wang W; Luo P; Guo W; Shi Y; Xu D; Zheng H; Jia L
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1927-1933. PubMed ID: 30072099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-181d-5p-FOXP1 feedback loop modulates the progression of osteosarcoma.
    Chen H; Xiao Z; Yu R; Wang Y; Xu R; Zhu X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1434-1441. PubMed ID: 30031607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental pathways hijacked by osteosarcoma.
    Mortus JR; Zhang Y; Hughes DP
    Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF kappa B in human osteosarcoma.
    Andela VB; Siddiqui F; Groman A; Rosier RN
    J Clin Pathol; 2005 Mar; 58(3):328-30. PubMed ID: 15735172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
    Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
    J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Runx2 in breast cancer-mediated bone metastasis.
    Vishal M; Swetha R; Thejaswini G; Arumugam B; Selvamurugan N
    Int J Biol Macromol; 2017 Jun; 99():608-614. PubMed ID: 28268169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.